Results 81 to 90 of about 15,403 (196)

The potential therapeutic role of Lisinopril in augmenting the striatal neuroplasticity via the striatal ACE2/Ang1-7/MAS receptor axis in 3-nitropropionic acid-induced Huntington’s disease in rats: shifting paradigms in Huntington’s disease treatment

open access: yesFuture Journal of Pharmaceutical Sciences
Background The exact pathogenesis of Huntington’s disease (HD) remains unclear. However, mitochondrial dysfunction and oxidative stress are supposed to play a significant role.
Hanaa Wanas   +11 more
doaj   +1 more source

Effect of Hibiscus sabdariffa (Calyxes) water extract on the in vitro availability of lisinopril

open access: yes, 2019
Background: The concurrent use of herbs and drugs for the treatment of various ailments is a common practice amongst patients; a practice that could result in drug-herb interaction.Objectives: This study is aimed at evaluating the effects of Hibiscus ...
Aminu, M   +4 more
core   +1 more source

Renal Toxicity of Lisinopril and Rosuvastatin, Alone and in Combination, in Wistar Rats

open access: yes, 2011
The aim of study was to evaluate the effect of commonly used lisinopril, rosuvastatin and their combined action on site-specific nephrotoxicity in rats using clusterin and microalbumin nephrotoxic biomarkers and other related parameters using oral ...
Sunita S. Goswami   +2 more
core   +1 more source

Development of a lisinopril (5 mg) formulation

open access: yes, 2008
Se describe el desarrollo de diferentes variantes tecnológicas de tabletas de Lisinopril (5 mg de dosis). Se evaluó el efecto de diferentes excipientes sobre la calidad tecnológica de los comprimidos a partir de un diseño de experimento 22.
González Castillo, Tahimí   +1 more
core  

Analisis efektivitas-biaya lisinopril dibandingkan captopril pada pasien hipertensi dengan diabetes melitus di Puskesmas Jagir Surabaya [PDF]

open access: yes, 2015
Bervariasinya penggunaan terapi antihipertensi untuk pasien hipertensi dengan diabetes melitus mengakibatkan adanya perbedaan dalam biaya dan efektivitas terapinya.
Da Silva, Katharina Irna
core  

Development of a lisinopril (5 mg) formulation

open access: yes, 2004
Se describe el desarrollo de diferentes variantes tecnológicas de tabletas de Lisinopril (5 mg de dosis). Se evaluó el efecto de diferentes excipientes sobre la calidad tecnológica de los comprimidos a partir de un diseño de experimento 22.
González Castillo, Tahimí   +1 more
core  

Synthesis and Characterization of Compounds Related to Lisinopril

open access: yes, 2015
Lisinopril is a drug of the angiotensin-converting enzyme (ACE) inhibitor class that is primarily used in the treatment of hypertension. During the scale-up of the lisinopril process, one unknown impurity was observed and is identified.
Srinivas GARAGA   +4 more
core   +1 more source

Severe hyponatremia: An association with lisinopril?

open access: yes, 1990
A 63-year-old white women with a history of hypertension and chronic obstructive pulmonary disease presented to the emergency room with worsening shortness of breath, anorexia, coughing, increased thirst, and leg edema of two weeks\u27 duration ...
Jack, W., Hume, A. L., Levinson, P.
core   +1 more source

Angiotensin II receptor antagonist and ACE inhibitor effectiveness in cognitive function correction among elderly patients with arterial hypertension

open access: yesКардиоваскулярная терапия и профилактика, 2007
Aim. To assess and compare 6-month monotherapy effectiveness for losartan and lisinopril, according to their effects on blood pressure (BP), vascular elasticity, and cognitive function in patients with Stage I-II arterial hypertension (AH). Material and
S. V. Nedogoda   +2 more
doaj  

Pengaruh Pelarut terhadap Optimasi Reaksi Derivatisasi Lisinopril dengan 1-Fluoro-2,4-Dinitrobenzene serta Pemilihan Standar Internalnya

open access: yes, 2016
Telah dilakukan penelitian untuk mengoptimasi reaksi derivatisasi lisinopril dalam pelarut aquades dan metanol dengan 1-fluoro-2,4-dinitrobenzene (FDNB) serta memilih standard internal.
Sumiyani, Ririn   +2 more
core  

Home - About - Disclaimer - Privacy